DDOST and metabolic dysfunction-associated steatohepatitis: Following the establishment of the NASH with T2DM mouse model, mice were subjected to tail vein infection with AAV9-AGER1 or AAV9-GFP (Control) followed by HFD feeding for another 6 weeks (Fig. 6a).